Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a steroid one
Crossref DOI link: https://doi.org/10.1007/s10792-017-0594-3
Published Online: 2017-06-21
Published Print: 2018-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tikhonovich, Marina V.
Erdiakov, Aleksei K.
Gavrilova, Svetlana A.
Funding for this research was provided by:
Russian Foundation for Basic Research grant (14-04-01318-A)
License valid from 2017-06-21